CLAC3A
- 总结
- The cartilage-specific CLEC3A has antimicrobial activity against some of the most common nosocomial bacteria with lack of own immunogenicity and is suitable for surface coating of prostheses.
- 技术优势
- Potent antibiotic activity against both Gram-positive and Gram-negative nosocomial Bacteria
No immunogenicity due to the protein`s natural expression in cartilage
No cytotoxicity against human cell
Suitable for surface coating of prostheses and dental implants
- 技术应用
- Reducing infections such as those from joint replacement and dental implant surgery.
- 详细技术说明
- peptides of the cartilage-specific CLEC3A kill both Gram-positive and Gram-negative nosocomial bacteria (Figure A). Furthermore, coating these antimicrobial peptides on titanium substrates significantly reduces bacterial adhesion on titanium substrates (Figure B). Coating of prostheses and dental implants with CLEC3A-derived antimicrobial peptides could therefore be an effective way of preventing infection without cytotoxicity and immunogenicity issues.
- 合作类型
- Licensing
- 申请日期
- 12/06/2018 00:00:00
- 其他
- Patent application
- ID号码
- 5125
- 国家/地区
- 德国

欲了解更多信息,请点击 这里